Cefuroxime is NOT appropriate for Pseudomonas aeruginosa infections
Cefuroxime has no clinically useful activity against Pseudomonas aeruginosa and should never be used to treat these infections. This is a critical point that could lead to treatment failure and patient harm if overlooked.
Why Cefuroxime Fails Against Pseudomonas
Cefuroxime is a second-generation cephalosporin that lacks anti-pseudomonal activity. The FDA label 1 and older literature 2 explicitly state that cefuroxime "has no effect against infections caused by Pseudomonas aeruginosa." This is not a resistance issue—it's an intrinsic lack of spectrum coverage.
The historical data confirms this: while cefuroxime shows activity against many gram-negative organisms including Haemophilus influenzae, Klebsiella, and Enterobacter species 2, it was never designed to cover Pseudomonas. Studies from the 1980s comparing various cephalosporins found that only agents like cefoperazone had "potent activity against Ps. aeruginosa" 3, 4, while cefuroxime did not.
What You Should Use Instead
For Pseudomonas aeruginosa infections, current guidelines 5, 6 recommend:
First-line options (if susceptible):
- Ceftolozane-tazobactam (preferred for pneumonia) 7
- Ceftazidime-avibactam (equally effective for non-pulmonary infections) 7
- Piperacillin-tazobactam (if susceptible) 6
- Ceftazidime or Cefepime (if susceptible) 6
For difficult-to-treat resistant (DTR) Pseudomonas:
- Ceftolozane-tazobactam or ceftazidime-avibactam as first choice 5, 7
- Imipenem-relebactam or cefiderocol when resistance to above agents exists 7
- Cefiderocol specifically when metallo-beta-lactamases are present 5, 7
Dosing considerations:
Recent evidence shows that adequate dosing is critical. For cefepime in bacteremia, 6 g/day (2 g q8h) resulted in significantly lower mortality (9%) compared to 4 g/day (1 g q6h) which had 44% mortality 8. This underscores that even appropriate agents fail if underdosed.
Clinical Pitfalls to Avoid
- Never assume a "cephalosporin" covers Pseudomonas—only specific anti-pseudomonal cephalosporins (ceftazidime, cefepime, ceftolozane) have this activity
- Check susceptibilities carefully—Pseudomonas develops resistance rapidly, even during therapy 7
- Consult infectious diseases—these infections carry high mortality and require expert management 9
If you have a culture growing Pseudomonas and are considering cefuroxime, stop and choose an anti-pseudomonal agent immediately based on susceptibility testing. Using cefuroxime will result in treatment failure.